Although previous studies confirmed the down-expression of GNG2 in malignant melanoma [54] and pancreatic ductal adenocarcinoma (PDAC) [55] cancers, there has been no discussion so far about the role of GNG2 in breast cancer and its metastasis to the brain. Here, GNG2 is linked to pancreatic ductal adenocarcinoma.